Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment--a review.
about
Status of hormones and painkillers in wastewater effluents across several European states-considerations for the EU watch list concerning estradiols and diclofenacBiogas generation in anaerobic wastewater treatment under tetracycline antibiotic pressureAntibiotics in Wastewater of a Rural and an Urban Hospital before and after Wastewater Treatment, and the Relationship with Antibiotic Use-A One Year Study from VietnamOrganic Pollutants in Shale Gas Flowback and Produced Waters: Identification, Potential Ecological Impact, and Implications for Treatment Strategies.The contribution of pharmaceutically active compounds from healthcare facilities to a receiving sewage treatment plant in Canada.Ranking prescribed pharmaceuticals in terms of environmental risk: Inclusion of hospital data and the importance of regular review.An Assessment of the Spatial and Temporal Variability of Biological Responses to Municipal Wastewater Effluent in Rainbow Darter (Etheostoma caeruleum) Collected along an Urban Gradient.Removal and seasonal variability of selected analgesics/anti-inflammatory, anti-hypertensive/cardiovascular pharmaceuticals and UV filters in wastewater treatment plant.Impact of selected non-steroidal anti-inflammatory pharmaceuticals on microbial community assembly and activity in sequencing batch reactors.Contaminants of emerging concern in a large temperate estuaryPotential ecological footprints of active pharmaceutical ingredients: an examination of risk factors in low-, middle- and high-income countries.Removal of amoxicillin from wastewater by self-made Polyethersulfone membrane using nanofiltration.Continuous fungal treatment of non-sterile veterinary hospital effluent: pharmaceuticals removal and microbial community assessment.Biodegradability of fluoxetine, mefenamic acid, and metoprolol using different microbial consortiums.Impact of treated wastewater irrigation on antibiotic resistance in the soil microbiome.Investigating the removal of some pharmaceutical compounds in hospital wastewater treatment plants operating in Saudi Arabia.Occurrence and preliminarily environmental risk assessment of selected pharmaceuticals in the urban rivers, China.Potential environmental implications of nano-enabled medical applications: critical review.Occurrence of PPCPs in the marine environment: a review.Ecological effects of pharmaceuticals in aquatic systems--impacts through behavioural alterations.Two-year survey of specific hospital wastewater treatment and its impact on pharmaceutical discharges.TOXICITY OF EXTRACTS FROM MUNICIPAL WASTEWATER TO EARLY LIFE STAGES OF JAPANESE MEDAKA (ORYZIAS LATIPES) TO EVALUATE REMOVALS OF MICROPOLLUTANTS BY WASTEWATER TREATMENT.Pharmaceuticals and personal care products: A critical review of the impacts on fish reproduction.Priority Substances and Emerging Organic Pollutants in Portuguese Aquatic Environment: A Review.Disposal of household pharmaceuticals in insular communities: social attitude, behaviour evaluation and prevention activities.Potential Upstream Strategies for the Mitigation of Pharmaceuticals in the Aquatic Environment: a Brief Review.Algal cultivation in urban wastewater: an efficient way to reduce pharmaceutical pollutants.Pharmaceuticals and personal care products (PPCPs) in urban and suburban rivers of Beijing, China: occurrence, source apportionment and potential ecological risk.Assessment of Household Disposal of Pharmaceuticals in Lebanon: Management Options to Protect Water Quality and Public Health.Do pharmaceuticals reach and affect the aquatic ecosystems in Brazil? A critical review of current studies in a developing country.Monitoring contaminants of emerging concern from tertiary wastewater treatment plants using passive sampling modelled with performance reference compounds.Paracetamol, aspirin and indomethacin display endocrine disrupting properties in the adult human testis in vitro.Occurrence and behavior of selected pharmaceuticals during riverbank filtration in The Republic of Serbia.Occurrence, fate, and risk assessment of vancomycin in two typical pharmaceutical wastewater treatment plants in Eastern China.Determination of levels of current drugs in hospital and urban wastewater.Systematic screening of common wastewater-marking pharmaceuticals in urban aquatic environments: implications for environmental risk control.Adsorption of sodium diclofenac on graphene: a combined experimental and theoretical study.Derivation of water quality guidelines for priority pharmaceuticals.Occurrence of selected pharmaceuticals in the principal sewage treatment plants in Rome (Italy) and in the receiving surface waters.Occurrence, seasonal variation and removal efficiency of antibiotics and their metabolites in wastewater treatment plants, Jiulongjiang River Basin, South China.
P2860
Q27313821-7480C4A3-01E0-4316-8A5B-55A56339516CQ28597325-40757970-54E9-4887-931D-78624EFCEF48Q28828689-5A3CDE0A-3E5A-4092-88BC-BA7189179BC7Q30357126-6BE1635E-9C66-43D2-A662-A3432BF2076DQ30976023-C9B0A42F-4354-4084-8658-827499063200Q31020572-6898D583-E1F6-411D-AFB9-DA3FA5350869Q31138731-E87D8C00-EDC5-4835-AA82-C1EE4AA98768Q31153546-F57965DC-2B4D-42F6-BD31-950A53DA0F5CQ33825237-ABA278FD-A9F2-4632-ADED-876AB6E648EDQ33902531-97446214-F3AF-44E0-89D0-A169C3A88666Q34423563-11E8B40E-E043-4219-AECF-2B60D91AD792Q35402274-02961C72-56EA-4FC4-97FB-21576C6537B7Q35833846-313864E7-D6C7-4F70-9F62-6BBCEAE7D690Q36250513-1EDA7F12-2987-4C37-A0C3-3826500A9C6EQ36821705-CC4530E5-2327-4215-9F4A-4D2AB085EC46Q37018650-B30DBA28-0460-4F8D-9816-62DACDBD51DEQ37319874-CB03FDD4-5A42-4BA6-853B-84B841D68754Q38193126-0961E527-D920-4982-9060-E06131150485Q38254047-3AB0C6DF-538B-42C3-BD00-B1678C8F964EQ38269160-35A3EC33-197C-4760-841A-8A9830D3E0A7Q38369673-218CF977-94F0-487D-9F5C-DF3757CD3BA6Q38403126-5DC66F6B-3854-4A5C-A123-16DACFBC1D26Q38461963-C4D5BECD-70FD-4544-8020-306DD10213EBQ38683522-D709CE91-974C-4ABE-B534-7C7D00C826B9Q38710264-18C66BD6-7354-4BCA-8E70-F013111B845FQ38805549-3D7F2F78-767C-4737-A49A-12913865241CQ38875276-5F68536E-0224-4291-8F56-11387BB155ECQ38894073-1F2F7549-2199-48EB-95F5-201876082A39Q38911810-99545E9A-D502-4BAE-816E-D8BA58143299Q38979288-292CF697-FE7C-4390-A621-F1ED2D8AA2E8Q39137598-EE174ED1-7393-47D9-9088-7D241BB8FFEAQ39152599-81D0085A-F7CB-4836-BD21-FF9AFB9104C3Q39215975-8457A493-CBD9-4C8C-8712-C738C9DAE581Q39774116-EEF74F8E-1C9E-48D7-BBE4-4A9EAE8A1A03Q40120678-4544CF22-FCB5-4629-97FE-797EB07048F5Q40172613-5A5A6377-3196-4659-82C4-F3F30BE2C91CQ40208571-8C5311BE-6FA8-4AB0-8306-D287CAA650CCQ40218435-4F1C223C-FC8C-4F73-8235-B72EC479535BQ40231461-CB114801-260D-4CC2-9490-5278A173EA4AQ40243535-70CF24A0-199D-472D-A82B-A76BDAF63731
P2860
Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment--a review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Occurrence of pharmaceutical c ...... secondary treatment--a review.
@en
type
label
Occurrence of pharmaceutical c ...... secondary treatment--a review.
@en
prefLabel
Occurrence of pharmaceutical c ...... secondary treatment--a review.
@en
P2093
P1476
Occurrence of pharmaceutical c ...... secondary treatment--a review.
@en
P2093
E Zambello
M Al Aukidy
P Verlicchi
P304
P356
10.1016/J.SCITOTENV.2012.04.028
P577
2012-05-12T00:00:00Z